Follow-up de crianças diagnosticadas com tdah e tratamento medicamentoso

• Ano de defesa: 2014
• Autor(a) principal: Muzzi, Maria do Carmo [UNIFESP]
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de São Paulo (UNIFESP)
• Palavras-chave em Português: adhd; methylphenidate; cognitive aspects; behavioral; emotional; tdah; metilfenidato; aspectos cognitivos; comportamentais; emocionais
• Link de acesso: https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=1309221; https://repositorio.unifesp.br/handle/11600/46148

Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common disorders in childhood and adolescence. It is characterized by a persistent pattern of inattention and / or hyperactivity / impulsivity. The precise causes of ADHD are still unknown, despite the large number of previous studies. The influence of genetic and environmental factors in their development is widely accepted in the literature. The symptoms of inattention, hyperactivity and impulsivity, consequently bring a great impact on academic development, as well as in the neurodevelopmental and psychosocial interaction areas. Also it reflects consistently in adaptive functioning and emotional self-regulation. The therapeutic intervention of ADHD involves a multimodal approach, including psychosocial and pharmacological interventions. The literature shows stimulants as first-choice medications, including methylphenidate, showing efficacy. Treatment with stimulants for ADHD leads to an improvement of symptoms throughout the day. The clinical goal of treatment is not limited only to improve the symptoms, but also to promote optimal functionality in emotional, behavioral, academic and social domains. The aim of this study was to seek correlations between results related to cognition, emotion and behavior in a sample of children and adolescents diagnosed with ADHD. We used for this purpose a few instruments including the Continuous Performance Test (CPT), computerized visual task. In addition, questionnaires completed by parents and school that contained behavioral and emotional information were employed. These procedures were performed before and after use of the medicine methylphenidate. The total sample for this study consisted of 12 male children and 1 female, aged between 6 and 14 years. After assessment, they received medicine treatment with methylphenidate, and after a period of 6 months were subjected to reassessment. After reassessment, the results indicated that there was a reduction in mean and median for all domains, only the index related to depression did not show a statistically significant difference. The data obtained from these results indicate a reduction of clinical, cognitive, emotional and behavioral symptomatology whose indices obtained effect size of large magnitude.